Study Shows Inherited Alzheimer's May Be Transmittable in Mice
Breakthrough Study on Alzheimer's Transmission
A recent study has uncovered a potential new way Alzheimer's disease might be transmitted. Researchers have discovered evidence in mice that suggests the inherited form of the disease could be passed through bone marrow donation. While this finding is preliminary and has yet to be confirmed in humans, it opens up new avenues for understanding Alzheimer's transmission. The study highlights the importance of continued research in this area to fully grasp the risks involved.
Understanding Amyloid Precursor Protein (APP)
At the heart of Alzheimer's research is the amyloid precursor protein, or APP. APP plays several crucial roles in the body but can also be converted into amyloid beta, a protein linked to Alzheimer's. In individuals with Alzheimer’s, a misfolded version of amyloid beta accumulates in the brain, forming clumps known as plaques. These plaques disrupt normal brain function and are a hallmark of the disease. Understanding APP is key to unraveling the complexities of Alzheimer's.
Linking Bone Marrow to Alzheimer's Risk
Most Alzheimer's cases are influenced by multiple factors, including age-related brain changes. However, some genetic mutations can significantly increase the risk, often leading to earlier onset. These mutations affect the APP gene, which is active not only in the brain but also in bone marrow cells. This discovery led scientists to explore whether bone marrow cells could contribute to the development of Alzheimer's. The presence of APP-producing cells outside the brain raises intriguing questions about the disease's transmission pathways.
The Mouse Transplantation Experiment
The research team conducted an innovative experiment using mice to test their hypothesis. They bred mice with a defective APP gene, ensuring they would develop Alzheimer's-like symptoms. The bone marrow from these affected mice was then transplanted into two groups of healthy mice: one group with a normal APP gene and another without any APP gene. Remarkably, both groups began to exhibit cognitive impairments and plaque buildup in their brains, mirroring Alzheimer's symptoms. This experiment suggests that the mutated APP gene can be transferred and potentially trigger the disease.
Potential Risks and Safety Measures
While the findings are significant, the risk of Alzheimer's transmission through bone marrow transplantation in humans appears to be low. Previous instances of disease transmission through medical procedures have been rare and specific. Nevertheless, the study's results underline the need for stringent screening of donors to prevent any inadvertent transfer of the disease. Experts advocate for comprehensive testing of blood, tissue, organ, and stem cell donors to enhance the safety of medical treatments and transfusions.
Conclusion: The Road Ahead in Alzheimer's Research
The study opens new doors for Alzheimer's research, highlighting the intricate ways the disease might spread. Researchers are keen to delve deeper into how donated APP-producing cells can trigger Alzheimer's, despite not becoming neurons themselves. Future studies may explore whether other types of transplants pose similar risks or if transplanting healthy cells could offer therapeutic benefits. As the scientific community continues to investigate, these findings pave the way for improved understanding and potential breakthroughs in combating Alzheimer's disease.
Read the full article here:
gizmodo.com